YourChoice Therapeutics is a company developing non-hormonal contraceptives for men.

YourChoice Therapeutics

YourChoice Therapeutics is building the family planning company of the 21st century. It is our mission to improve the health and well being of women and men by developing the non-hormonal contraceptive and fertility products they desperately need.

Nadja Mannowetz is an invited speaker at the 2024 International Retinoids Conference in Minnesota next week. Attending? She'll be speaking on July 10 at 4 pm.

It's been 2 years since a women's constitutional right to abortion was overturned. The The Associated Press' Geoff Mulvihill chronicles the impact on women's reproductive rights. The net: abortion rates haven't declined. They've just become inaccessible to women without the ability to travel across state lines.

#healthequity #womenshealthmatters #wecandobetter

https://lnkd.in/edi5KQVB

The future of birth control is hormone free. Shout out to FemHealth Insights for their research report.

The Male Contraceptive Initiative has been advancing hormone-free male birth control for ten years. Happy birthday and well-done! 

It's been 169 years since the male condom hit the market. That's too long to wait for innovation. Enter MCI, which believes the future of male birth control should be hormone-free. We're delivering on that future with the only hormone-free male birth control pill in human studies. We wouldn't be here without MCI, and we invite all to celebrate their achievements.

#innovation #change #healthequity #womenshealth #menshealth

Could more male birth control options be part of the solution to women's narrowing reproductive rights? Consider our CEO's view in his interview with Ron Leuty of the San Francisco Business Times while learning more about YCT-529, the first hormone-free birth control pill candidate for men.

#future #hormonefree #startups #research #success

Thank you, Better Birth Control e.V., for gathering an outstanding international group of people and organizations working tirelessly to improving birth control options for men and women. We were honored to share our work on the first hormone-free birth control pill for men, and of course, join our colleagues from the Male Contraceptive Initiative. Please invite us again!

Metric
Company Name	YourChoice Therapeutics
Symbol
MSH ID	COM:YOURCHOICETX
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Pharmaceuticals
Country	US
Stage
Employee Count	4
Website	yourchoicetx.com
LinkedIn	yourchoicetherapeutics
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:YOURCHOICETX

YourChoice Therapeutics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue